Technetium-99m-ubiquicidin 29-41 SPECT-CT to detect postsurgical spinal infection: A case report
- PMID: 38344098
- PMCID: PMC10858759
- DOI: 10.25259/SNI_698_2023
Technetium-99m-ubiquicidin 29-41 SPECT-CT to detect postsurgical spinal infection: A case report
Abstract
Background: Postsurgical spinal infections are a severe complication and a challenge to the neurosurgeon due to their complex management. Revision surgeries and the removal of hardware are usually necessary. Recently, advances in nuclear medicine have made it possible to employ radiotracers to identify infections. The radiolabeled antimicrobial peptide technetium-99m-ubiquicidin (99mTc-UBI) (29-41) has been demonstrated to detect bacterial infections. UBI 29-41 is a peptide sequence with selective binding to the anionic cell membrane of bacteria, which has recently been used to differentiate between infection and inflammation. Here, we describe the clinical utility of 99mTc-UBI 29-41 single-photon emission computed tomography-computed tomography (SPECT-CT) in a patient suspected of a postoperative infection.
Case description: A 54-year-old male who presented with conus medullaris syndrome secondary to T12 spondylodiscitis and multiple abscess collections was initially managed with debridement, corpectomy, and minimally invasive lateral instrumentation. The patient developed postsurgical empyema near the surgical site. The image study avoided the need for a second surgery and hardware removal.
Conclusion: The use of 99mTc-UBI 29-41 SPECT-CT served as a tool to avoid a second invasive procedure; instead, conservative management with antibiotics was performed with an effective outcome after two weeks. This radiotracer has utility in cases in which infection is suspected, but the location is not entirely clear, and information is needed to guide the therapeutic approach.
Keywords: Nuclear medicine; Postsurgical infection; Single-photon emission computed tomography; Spinal infection; Ubiquicidin.
Copyright: © 2024 Surgical Neurology International.
Conflict of interest statement
There are no conflicts of interest.
Figures

Similar articles
-
Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations.Eur J Nucl Med. 2000 Mar;27(3):292-301. doi: 10.1007/s002590050036. Eur J Nucl Med. 2000. PMID: 10774881
-
Clinical utility of 99mTc-ubiquicidin (29-41) as an adjunct to bone scan in differentiating infected versus noninfected loosening of prosthesis before revision surgery.Nucl Med Commun. 2017 Apr;38(4):285-290. doi: 10.1097/MNM.0000000000000648. Nucl Med Commun. 2017. PMID: 28244975
-
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus.J Nucl Med. 2004 Feb;45(2):321-6. J Nucl Med. 2004. PMID: 14960656
-
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT.Curr Radiopharm. 2019;12(3):171-186. doi: 10.2174/1874471012666190206102214. Curr Radiopharm. 2019. PMID: 30727939 Review.
-
99mTc-Ubiquicidin29-41.2007 Jul 31 [updated 2007 Sep 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Jul 31 [updated 2007 Sep 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641940 Free Books & Documents. Review.
References
-
- Marjanovic-Painter B, Kleynhans J, Zeevaart JR, Rohwer E, Ebenhan T. A decade of ubiquicidin development for PET imaging of infection: A systematic review. Nucl Med Biol. 2023;116-7:108307. - PubMed
-
- Shinto AS, Mukherjee A, Karuppusamy KK, Joseph J, Bhatt J, Korde A, et al. Clinical utility of 99mTc-ubiquicidin (29-41) as an adjunct to bone scan in differentiating infected versus noninfected loosening of prosthesis before revision surgery. Nucl Med Commun. 2017;38:285–90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources